Brain radiation and memory: new study maps hidden risks
NCT ID NCT04390906
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 75 adults with benign or slow-growing brain tumors who are receiving partial brain radiation. Researchers will use memory tests and MRI scans before treatment and at 6 and 12 months after to see how radiation affects thinking and memory. The goal is to identify which brain structures are most vulnerable to radiation damage, so future treatments can be designed to protect them.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- partial brain radiation therapy
- What this could lead to
- If successful, this study could help doctors design safer radiation plans that spare key brain areas and reduce memory problems after treatment.
- What could go wrong
- This is a small pilot study, not a treatment trial. It only observes changes and cannot prove that any new approach improves outcomes. Results may not apply to all brain tumor patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACOUSTIC NEUROMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
James P. Wilmot Cancer Center at University of Rochester Medical Center
Rochester, New York, 14642, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a parasite drug fight childhood brain tumors?
- A new PET scan tracks brain tumors by their appetite for tryptophan
- Can a simple dye help surgeons see brain tumors in real time?
- Could blocking a Tumor's blood supply shrink brain meningiomas?
- New platform trial takes on NF2 tumors with multiple drug strategies
- Digital tests may offer a new way to track brain health in tumor patients